ExodusPoint Capital Management’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-29,552
| Closed | -$81K | – | 1572 |
|
2024
Q3 | $81K | Buy |
+29,552
| New | +$81K | ﹤0.01% | 1404 |
|
2021
Q3 | – | Sell |
-42,042
| Closed | -$135K | – | 2227 |
|
2021
Q2 | $135K | Buy |
+42,042
| New | +$135K | ﹤0.01% | 2006 |
|
2019
Q2 | – | Sell |
-70,854
| Closed | -$362K | – | 1160 |
|
2019
Q1 | $362K | Buy |
70,854
+36,254
| +105% | +$185K | 0.03% | 408 |
|
2018
Q4 | $119K | Buy |
+34,600
| New | +$119K | 0.01% | 295 |
|